SCHEMBL9138396

SCHEMBL9138396

CCCCc1ncc(C=C2C(=O)N(CC(=O)O)c3ccccc32)n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 9/20 0.56
AGTR2 P50052 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9138388 1.00 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9136470 0.91 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9136465 0.91 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9298365 0.86 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9135768 0.86 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9138345 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9138489 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9138356 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL21 0.82 AGTR1 (0.69) AGTR1AGTR2
SCHEMBL9138189 0.80 AGTR1 (0.63) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5389661-A Treats hypertension, heart failure, glaucoma and hyperaldosteronism WARNER-LAMBERT COMPANY (US) 1995-02-14 US disclosed
US-5322950-A Treating hypertension, hyperaldosteronism, glaucoma, heart failure WARNER-LAMBERT COMPANY (US) 1994-06-21 US disclosed